Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$1.35B |
| 2 |
Microsoft
MSFT
|
+$1.33B |
| 3 |
S&P Global
SPGI
|
+$898M |
| 4 |
Advanced Micro Devices
AMD
|
+$845M |
| 5 |
Tesla
TSLA
|
+$823M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$307M |
| 4 |
Exelon
EXC
|
+$291M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| 1 | Technology | 25.4% |
| 2 | Financials | 13.31% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITOS
2176
DELISTED
iTeos Therapeutics
ITOS
| $12.9M | ﹤0.01% |
399,450
+25,662
| +7% | +$826K |
|
2177
LoveSac
LOVE
$250M
| $12.8M | ﹤0.01% |
237,659
+11,666
| +5% | +$631K |
|
2178
Schneider National
SNDR
$4.22B
| $12.8M | ﹤0.01% |
501,586
-283,826
| -36% | -$7.24M |
|
2179
Wabash National
WNC
$458M
| $12.8M | ﹤0.01% |
861,071
+40,629
| +5% | +$603K |
|
2180
Titan International
TWI
$548M
| $12.8M | ﹤0.01% |
866,243
+282
| +0% | +$4.15K |
|
2181
RPC Inc
RES
$1.02B
| $12.7M | ﹤0.01% |
1,194,710
+118,273
| +11% | +$1.26M |
|
2182
Rackspace Technology
RXT
$357M
| $12.7M | ﹤0.01% |
1,142,112
+4,061
| +0.4% | +$45.3K |
|
|
KDNY
2183
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $12.7M | ﹤0.01% |
777,066
+43,409
| +6% | +$710K |
|
2184
Microvision
MVIS
$343M
| $12.7M | ﹤0.01% |
2,720,945
-74,192
| -3% | -$346K |
|
|
SP
2185
DELISTED
SP Plus Corporation
SP
| $12.7M | ﹤0.01% |
404,829
+12,879
| +3% | +$404K |
|
2186
Rocket Lab Corporation Common Stock
RKLB
$24.1B
| $12.7M | ﹤0.01% |
1,574,913
+22,295
| +1% | +$179K |
|
2187
SunCoke Energy
SXC
$649M
| $12.7M | ﹤0.01% |
1,421,686
+35,357
| +3% | +$315K |
|
2188
Smith & Wesson
SWBI
$414M
| $12.7M | ﹤0.01% |
837,121
-54,064
| -6% | -$818K |
|
|
FBMS
2189
DELISTED
The First Bancshares, Inc.
FBMS
| $12.7M | ﹤0.01% |
375,834
+6,972
| +2% | +$235K |
|
2190
Lifestance Health
LFST
$2.04B
| $12.6M | ﹤0.01% |
1,249,362
+265,811
| +27% | +$2.69M |
|
2191
WisdomTree
WT
$2.06B
| $12.6M | ﹤0.01% |
2,150,131
+9,807
| +0.5% | +$57.6K |
|
2192
Sana Biotechnology
SANA
$836M
| $12.6M | ﹤0.01% |
1,526,711
-22,472
| -1% | -$186K |
|
2193
Caleres
CAL
$505M
| $12.6M | ﹤0.01% |
652,012
+18,605
| +3% | +$360K |
|
2194
Fulcrum Therapeutics
FULC
$368M
| $12.5M | ﹤0.01% |
530,137
+32,132
| +6% | +$760K |
|
2195
GoodRx Holdings
GDRX
$1.47B
| $12.5M | ﹤0.01% |
645,848
+13,166
| +2% | +$254K |
|
2196
Hillman Solutions
HLMN
$1.92B
| $12.4M | ﹤0.01% |
1,047,409
+37,328
| +4% | +$443K |
|
|
PRSU
2197
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $12.4M | ﹤0.01% |
349,157
+3,823
| +1% | +$136K |
|
2198
Collegium Pharmaceutical
COLL
$1.21B
| $12.4M | ﹤0.01% |
610,605
+5,468
| +0.9% | +$111K |
|
2199
Arlo Technologies
ARLO
$1.81B
| $12.4M | ﹤0.01% |
1,401,487
+29,257
| +2% | +$259K |
|
2200
IonQ
IONQ
$16.5B
| $12.4M | ﹤0.01% |
972,839
+19,816
| +2% | +$253K |
|